Profit Or Loss [Abstract]

Biotest AG - Filing #6464577

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
7,262,000,000 EUR
6,846,000,000 EUR
Other income
84,000,000 EUR
269,000,000 EUR
Profit (loss) from operating activities
945,000,000 EUR
1,435,000,000 EUR
Finance income
99,000,000 EUR
97,000,000 EUR
Finance costs
438,000,000 EUR
497,000,000 EUR
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9
79,000,000 EUR
1,000,000 EUR
Profit (loss) before tax
465,000,000 EUR
1,063,000,000 EUR
Tax expense (income)
202,000,000 EUR
207,000,000 EUR
Profit (loss)
EUR
264,000,000 EUR
EUR
EUR
EUR
264,000,000 EUR
EUR
1,270,000,000 EUR
EUR
1,270,000,000 EUR
EUR
EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
264,000,000 EUR
1,270,000,000 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
66.00
320.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
66.00
320.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.